Description
REAGENTS&COST PER REPORTABLE RESULTS (CPRR)
First action · last action
2011-10-24 · 2013-04-18
Transactions
2
First transaction's obligation
$240,000
Base + all options value (sum of deltas)
$6,145,763
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA256BP0109
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-10-24+$240,000= $240,000
- Mod P000012013-04-18-$32,696= $207,304
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-10-24 | +$240,000 | $240,000 | REAGENTS&COST PER REPORTABLE RESULTS (CPRR) |
| Mod P00001· FUNDING ONLY ACTION | 2013-04-18 | −$32,696 | $207,304 | REAGENTS&COST PER REPORTABLE RESULTS (CPRR) |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under Q301 from 598-NORTH LITTLE ROCK (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613P0129 | GENOMIC HEALTH, INC. | 598-NORTH LITTLE ROCK | $0 | FY2013 |
| VA25612J2411 | LABORATORY CORPORATION OF AMERICA | 598-NORTH LITTLE ROCK | $14,129 | FY2013 |
| VA25612J2413 | LABORATORY CORPORATION OF AMERICA | 598-NORTH LITTLE ROCK | $46,376 | FY2013 |
| VA25612J2268 | LABORATORY CORPORATION OF AMERICA | 598-NORTH LITTLE ROCK | $110,000 | FY2012 |
| VA25612J2051 | LABORATORY CORPORATION OF AMERICA | 598-NORTH LITTLE ROCK | $57,273 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25612F0126_3600_VA256BP0109_3600 · retrieved 2026-09-26.